FDA OKs extended duration of Allergan’s Liletta IUD

Allergan (AGN +0.1%) and nonprofit Medicines360 announce the FDA nod to extend the duration of use of LILETTA (levonorgestrel-releasing intrauterine system) 52 mg for the prevention of pregnancy for up to six years, the longest approved duration in the U.S. for an IUD.

Allergan leads commercialization while Medicines360 offers the device at a lower cost to public health clinics.

https://seekingalpha.com/news/3510082-fda-oks-extended-duration-allergans-liletta-iud